Heranba Industries Ltd., one of India’s leading Synthetic Pyrethroids and its intermediates manufacturer in India, Q4 FY22 revenue reached Rs. 350.1 crore, achieving a growth of 30.1% vis-a-vis Q4 FY21. 

 

Profit After Tax was flat at Rs. 42.6 crore in Q4 FY22 as compared to Rs. 43.3 crore in Q4 FY21.

 

Revenue from operations reached Rs. 1,450.4 crore in FY22 as compared to Rs. 1,218.6 crore in FY21, a growth of 19.02% whereas Profit After Tax reached Rs. 189.1 crore in FY22 as compared to Rs. 154.2 crore in FY21, a growth of 22.59%.

 

Raghuram K. Shetty, Managing Director, Heranba Industries Limited said, “I am pleased to announce that we have reported a strong set of numbers for the fiscal year 2021-22, wherein we saw an increase of 19% in our revenues and of 23% in our PAT numbers on a year-on-year basis. This along with EBITDA margin being in the guided range of 18% to 20%, we are set to carry the momentum in FY23.”

 

“Leveraging our integrated manufacturing facilities and wide distribution network, we are in pursuit of expanding our already diverse customer case by accelerating our product registrations across the globe in order to continue Heranba’s growth momentum,” commented Shetty. 

 

Heranba is a leading agrochemical company in India and its mission is to improve crop productivity and public health. The company manufactures Synthetic Pyrethroids and its intermediates in India and has four manufacturing facilities across India with employee strength of more than 650.